ema prac naion semaglutide june 2025 medicines such as Ozempic, Wegovy, and Rybelsus have been reviewed by UK and EU regulators in relation to a rare optic nerve condition called NAION. Swipe through for the key red Association between Semaglutide and Nonarteritic

Symptoms associated with gastroparesis include stomach pain, nausea, indigestion, loss of appetite, and vomiting

Gradual, Natural-Looking Results: The fat dissolves over time, creating a natural contour

23 (6), e13435

Always consult your healthcare provider to tailor this approach to your unique needs and medical history

Who GLP-1 weight loss is for - and who it isn't Patients we typically work with on GLP-1 weight management: Adults with BMI 30+ (obesity) who have not achieved sustained weight loss with lifestyle change alone Adults with BMI 27+ and weight-related comorbidities - type 2 diabetes, hypertension, dyslipidemia, sleep apnea, prediabetes, fatty liver disease Patients with insulin resistance or metabolic syndrome where the metabolic and weight pictures are intertwined Patients post-bariatric surgery with weight regain, where appropriate and coordinated with their surgical team GLP-1 medications are not appropriate for patients with personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, severe gastroparesis, or active eating disorders

NEXT READ: What Screenings Do Women Need at Every Age?